The use of a multidimensional measure of dialysis adequacy—moving beyond small solute kinetics

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 5, 2017, Pages 839-847

  Perl, Jeffrey ^a   Dember, Laura M ^b   Bargman, Joanne M ^a   Browne, Teri ^c   Charytan, David M ^d   Flythe, Jennifer E ^e   Hickson, Latonya J ^f   M Hung, Adriana ^g   Jadoul, Michel ^h   Lee, Timmy Chang ⁱ   Meyer, Klemens B ^j   Moradi, Hamid ^k   Shafi, Tariq ^l   Teitelbaum, Isaac ^m   Wong, Leslie ⁿ   Chan, Christopher T ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f MAYO CLINIC   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁱ UNIVERSITY OF ALABAMA   (United States)

^j TUFTS MEDICAL CENTER   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF COLORADO   (United States)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

Dialysis dos; Dialysis Physiology; Patient Reported Outcomes; Urea Kinetics

Indexed keywords

CREATININE; PHOSPHATE; POTASSIUM; UREA; BIOLOGICAL MARKER; DIALYSIS FLUID;

AORTIC ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER; CLINICAL OUTCOME; DIALYSIS; END STAGE RENAL DISEASE; ERYTHROPOIESIS; EXTRACELLULAR SPACE; HEART RATE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; KINETICS; MEMBRANE PERMEABILITY; MORBIDITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SOLUTE; SURVIVAL; ULTRAFILTRATION; UREMIA; BIOLOGICAL MODEL; BLOOD; CHRONIC KIDNEY FAILURE; FLUID THERAPY; HEALTH CARE QUALITY; METABOLISM; MORTALITY; PATIENT-REPORTED OUTCOME; PREDICTIVE VALUE; QUALITY CONTROL; STANDARDS; TREATMENT OUTCOME;

BIOMARKERS; DIALYSIS SOLUTIONS; FLUID THERAPY; HUMANS; KIDNEY FAILURE, CHRONIC; KINETICS; MODELS, BIOLOGICAL; PATIENT REPORTED OUTCOME MEASURES; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; QUALITY CONTROL; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; RENAL DIALYSIS; TREATMENT OUTCOME; UREA;

EID: 85021744579     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08460816     Document Type: Review

References (95)

1. Babb AL, Popovich RP, Christopher TG, Scribner BH: The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 17: 81-91, 1971
2. Shinaberger JH, Miller JH, Rosenblatt MG, Gardner PW, Carpenter GW, Martin FE: Clinical studies of ‘low flow’ dialysis with membranes highly permeable to middle weight molecules. Trans Am Soc Artif Intern Organs 18: 82-84, 1972
3. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescriptionofpatientmorbidity: report fromtheNational CoorperativeDialysis Study. NEng J Med 305: 1176-1181, 1981
4. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534, 1985
5. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Hemodialysis (HEMO) study Group: effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
6. Meyer TW, Sirich TL, Fong KD, Plummer NS, Shafi T, Hwang S, Banerjee T, Zhu Y, Powe NR, Hai X, Hostetter TH: Kt/V urea and nonurea small solute levels in the hemodialysis study. J Am Soc Nephrol 27: 3469-3478, 2016
7. Daugirdas JT: Dialysis dosing for chronic hemodialysis: Beyond Kt/V. Semin Dial 27: 98-107, 2014
8. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d’Avolio G, Gelatti U: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 10: 2295-2305, 1995
9. Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198-207, 1996
10. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. JAmSoc Nephrol 12: 2158-2162, 2001
11. Paniagua R, Amato D, Vonesh E, Guo A, Mujais S; Mexican NephrologyCollaborative StudyGroup:Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial. Kidney Int 67: 1093-1104, 2005
12. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, Ng FS, Cheng IK: Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 64: 649-656, 2003
13. Fried L, Hebah N, Finkelstein F, Piraino B: Association of Kt/Vand creatinine clearance with outcomes in anuric peritoneal dialysis patients. Am J Kidney Dis 52: 1122-1130, 2008
14. Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP: Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 79: 218-227, 2011
15. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999-1007, 2007
16. Torlén K, Kalantar-Zadeh K, Molnar MZ, Vashistha T, Mehrotra R: Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin J Am Soc Nephrol 7: 1272-1284, 2012
17. Block GA, Hulbert-Shearon TE, Levin NW, Port FK:Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study.AmJ Kidney Dis 31: 607-617, 1998
18. Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT: Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: An updated systematic review and meta-analysis. Lancet 382: 1268-1277, 2013
19. Parfrey PS, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Dehmel B, Trotman ML, Modafferi DM, Goodman WG: The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: TheEVOLVEtrial. J ClinEndocrinolMetab 98: 4834-4844, 2013
20. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and BoneDisorder (CKD-MBD). Kidney Int Suppl 113: S1-S130, 2009
21. Meyer TW, Hostetter TH: Uremia.NEngl JMed357: 1316-1325, 2007
22. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 14: 3251-3263, 2003
23. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R; Membrane Permeability Outcome (MPO) Study Group: Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20: 645-654, 2009
24. Schouten WE, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nubé MJ: Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 15: 379-384, 2000
25. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S; Frequent Hemodialysis Network Trial Group: Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 8: 2106-2116, 2013
26. Eloot S, Schneditz D, Cornelis T, Van Biesen W, Glorieux G, Dhondt A, Kooman J, Vanholder R: Protein-bound uremic toxin profiling as a tool to optimize hemodialysis. PLoS One 11: e0147159, 2016
27. Eloot S, Van Biesen W, Dhondt A, Van deWynkele H, Glorieux G, Verdonck P, Vanholder R: Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73: 765-770, 2008
28. Eloot S, Schneditz D, Vanholder R: What can the dialysis physician learn from kinetic modelling beyond Kt/V(urea)? Nephrol Dial Transplant 27: 4021-4029, 2012
29. Nesrallah GE, Lindsay RM, Cuerden MS, Garg AX, Port F, Austin PC, Moist LM, Pierratos A, Chan CT, Zimmerman D, Lockridge RS, Couchoud C, Chazot C, Ofsthun N, Levin A, Copland M, Courtney M, Steele A, McFarlane PA, Geary DF, Pauly RP, Komenda P, Suri RS: Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol 23: 696-705, 2012
30. Pauly RP, Gill JS, Rose CL, Asad RA, Chery A, Pierratos A, Chan CT: Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients.NephrolDialTransplant24: 2915-2919, 2009
31. Tennankore KK, Kim SJ, Baer HJ, Chan CT: Survival and hospitalization for intensivehome hemodialysis comparedwith kidney transplantation. J Am Soc Nephrol 25: 2113-2120, 2014
32. Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS; FHN Trial Group: Long-term effects of frequent nocturnal hemodialysis on mortality: The Frequent Hemodialysis Network (FHN) nocturnal trial. Am J Kidney Dis 66: 459-468, 2015
33. Lacson Jr. E, Wang W, Lester K, Ofsthun N, Lazarus JM, Hakim RM: Outcomes associated with in-center nocturnal hemodialysis froma largemulticenter program. Clin J AmSoc Nephrol 5: 220-226, 2010
34. Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV: Association between depression andmortality in patients receiving long-term dialysis: A systematic review andmeta-analysis. AmJ Kidney Dis 63: 623-635, 2014
35. Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, Switzer GE: Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 16: 2487-2494, 2005
36. Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB; HEMO Study Group: Effects of hemodialysis dose andmembrane flux on health-related quality of life in the HEMO Study. Kidney Int 66: 355-366, 2004
37. Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R; Daily Hemodialysis Study Group London Health Sciences Centre: Minutes to recovery after a hemodialysis session:Asimple healthrelated quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol 1: 952-959, 2006
38. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS; FHN Trial Group: In-center hemodialysis six times perweek versus three times perweek.NEngl J Med 363: 2287-2300, 2010
39. Jaber BL, Lee Y, Collins AJ, Hull AR, Kraus MA, McCarthy J, Miller BW, Spry L, Finkelstein FO; FREEDOM Study Group: Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: Interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis 56: 531-539, 2010
40. Finkelstein FO, Schiller B, Daoui R, Gehr TW, Kraus MA, Lea J, Lee Y, Miller BW, Sinsakul M, Jaber BL: At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int 82: 561-569, 2012
41. Bass EB, Wills S, Fink NE, Jenckes MW, Sadler JH, Levey AS, Meyer K, Powe NR: How strong are patients’ preferences in choices between dialysis modalities and doses?AmJ KidneyDis 44: 695-705, 2004
42. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K: Dialysis modality preference of patients with CKD and family caregivers: A discrete-choice study. Am J Kidney Dis 60: 102-111, 2012
43. National Kidney Foundation: KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66: 884-930, 2015
44. Lee MB, Bargman JM: Survival by dialysis modality-who cares? Clin J Am Soc Nephrol 11: 1083-1087, 2016
45. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119: 671-679, 2009
46. Cabrera C, Brunelli SM, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO, Stefánsson BV: A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients. BMC Nephrol 16: 113, 2015
47. Movilli E, Camerini C, Gaggia P, Zubani R, Feller P, Poiatti P, Pola A, Carli O, Cancarini G: Magnitude of end-dialysis overweight is associated with all-cause and cardiovascular mortality: A 3-year prospective study. Am J Nephrol 37: 370-377, 2013
48. Flythe JE, Kshirsagar AV, Falk RJ, Brunelli SM: Associations of posthemodialysis weights above and below target weight with all-cause and cardiovascular mortality. Clin J Am Soc Nephrol 10: 808-816, 2015
49. Passauer J, Petrov H, Schleser A, Leicht J, Pucalka K: Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: A cross-sectional study. Nephrol Dial Transplant 25: 545-551, 2010
50. Hussein WF, Arramreddy R, Sun SJ, Doss-McQuitty S, Schiller B: Blood volume monitoring to assist fluid management in hemodialysis patients. Am J Kidney Dis 67: 166-168, 2016
51. Sharpe N: Left ventricular remodeling: Pathophysiology and treatment. Heart Fail Monit 4: 55-61, 2003
52. Cotter G, Felker GM, Adams KF, Milo-Cotter O, O’Connor CM: The pathophysiology of acute heart failure-is it all about fluid accumulation? Am Heart J 155: 9-18, 2008
53. Antzelevitch C. Mechanisms of Cardiac Arrhythmias and Conduction Disturbances. In: Hurst’s The Heart, 12th Ed., edited by Fuster V, O’Rourke R, Walsh R, Poole-Wilson P, New York, McGraw-Hill, 2008
54. Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E: Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: A randomized controlled trial. Am J Kidney Dis 61: 957-965, 2013
55. Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, Covic AC: Bioimpedance-guided fluid management in maintenance hemodialysis: A pilot randomized controlled trial. Am J Kidney Dis 64: 111-118, 2014
56. Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen Jr.WF: Intradialytic blood volume monitoring in ambulatory hemodialysis patients: A randomized trial. J AmSoc Nephrol 16: 2162-2169, 2005
57. Sinha AD, Light RP, Agarwal R: Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight. Hypertension 55: 305-311, 2010
58. Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G: Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 22: 3547-3552, 2007
59. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associatedwith cardiovascularmorbidityandmortality. Kidney Int 79: 250-257, 2011
60. Flythe JE, Assimon MM, Wenger JB, Wang L: Ultrafiltration rates and the quality incentive program: Proposed measure definitions and their potential dialysis facility implications. Clin J Am Soc Nephrol 11: 1422-1433, 2016
61. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced cardiac injury: Determinants and associated outcomes. Clin J Am Soc Nephrol 4: 914-920, 2009
62. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4: 1925-1931, 2009
63. London GM, Drueke TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51: 1678-1695, 1997
64. Bolli R, Zhu WX, Thornby JI, O’Neill PG, Roberts R: Time course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol 254: H102-H114, 1988
65. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF: Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 56: 978-985, 1975
66. Pereira AA, Weiner DE, Scott T, Sarnak MJ: Cognitive function in dialysis patients. Am J Kidney Dis 45: 448-462, 2005
67. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK: Circulating endotoxemia: A novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 6: 133-141, 2011
68. Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, Chertow GM: Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol 22: 1526-1533, 2011
69. Günal AI, Duman S, Ozkahya M, Töz H, Asççi G, Akçiçek F, Basçi A: Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 37: 588-593, 2001
70. Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM: Recovery time, quality of life, and mortality in hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 64: 86-94, 2014
71. Kalantar-Zadeh K, Unruh M, Zager PG, Kovesdy CP, Bargman JM, Chen J, Sankarasubbaiyan S, Shah G, Golper T, Sherman RA, Goldfarb DS: Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64: 181-186, 2014
72. Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, Chen J, Mathew AT, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K: Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: A cohort study. Am J Kidney Dis 68: 256-265, 2016
73. Robinson BM, Zhang J, Morgenstern H, Bradbury BD, Ng LJ, McCullough KP, Gillespie BW, Hakim R, Rayner H, Fort J, Akizawa T, Tentori F, Pisoni RL:Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 85: 158-165, 2014
74. Schachter ME, Chan CT:Current state of intensive hemodialysis:A comparative review of benefits and barriers. Nephrol Dial Transplant 27: 4307-4313, 2012
75. Slinin Y, Greer N, Ishani A, MacDonald R, Olson C, Rutks I, Wilt TJ: Timing of dialysis initiation, duration and frequency of hemodialysis sessions, andmembrane flux:Asystematic reviewfor a KDOQIclinical practice guideline.AmJKidney Dis 66: 823-836, 2015
76. U.S. Renal Data System: USRDS 2015 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2015
77. Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Association between serum bicarbonate and death in hemodialysis patients: Is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol 1: 70-78, 2006
78. Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, Criollo A, Nemchenko A, Hill JA, Lavandero S: Cardiomyocyte death:Mechanismsandtranslationalimplications. CellDeathDis 2: e244, 2011
79. Kovacic V, Ljutic D, Dodig J, Radic M, Duplancic D: Influence of haemodialysis on early markers of atherosclerosis. Nephrology (Carlton) 13: 472-479, 2008
80. Chan CT, Chertow GM, Daugirdas JT, Greene TH, Kotanko P, Larive B, Pierratos A, Stokes JB; Frequent Hemodialysis Network Daily Trial Group: Effects of daily hemodialysis on heart rate variability: Results from the Frequent Hemodialysis Network (FHN) daily trial. Nephrol Dial Transplant 29: 168-178, 2014
81. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365: 1099-1107, 2011
82. Abdel-Kader K, Unruh ML, Weisbord SD: Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol 4: 1057-1064, 2009
83. Mehrotra R, Agarwal A, Bargman JM, Himmelfarb J, Johansen KL, Watnick S, Work J, McBryde K, Flessner M, Kimmel PL; Kidney Research National Dialogue (KRND): Dialysis therapies: A National Dialogue. Clin J Am Soc Nephrol 9: 812-814, 2014
84. Moss AH, Davison SN: How the ESRD quality incentive program could potentially improve quality of life for patients on dialysis. Clin J Am Soc Nephrol 10: 888-893, 2015
85. Nissenson AR: Improving outcomes for ESRD patients: Shifting the quality paradigm. Clin J Am Soc Nephrol 9: 430-434, 2014
86. Butman M, Nissenson AR: Dialysis outcomes as a measure of adequacy of dialysis. Semin Nephrol 25: 70-75, 2005
87. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G: Serum beta-2 microglobulin levels predict mortality in dialysis patients: Results of the HEMO study. J Am Soc Nephrol 17: 546-555, 2006
88. Coyne DW: Managing anemia in for-profit dialysis chains:When ethics and business conflict. Semin Dial 22: 18-21, 2009
89. Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC: Impact of the kidney disease outcomes quality initiative (KDOQI) clinical practice guidelines for bonemetabolism and disease in a large dialysis network. Am J Kidney Dis 49: 257-266, 2007
90. Krishnan M, Brunelli SM, Maddux FW, Parker TF 3rd, Johnson D, Nissenson AR, Collins A, Lacson E Jr: Guiding principles and checklist for population-based quality metrics. Clin J Am Soc Nephrol 9: 1124-1131, 2014
91. Maddux FW: Doing more than caring about quality. Semin Dial 29: 119-124, 2016
92. Vandecasteele SJ, Kurella Tamura M: A patient-centered vision of care for ESRD: Dialysis as a bridging treatment or as a final destination? J Am Soc Nephrol 25: 1647-1651, 2014
93. Tovbin D, Belfair N, Shapira S, Rosenthal G, Friger M, Feldman L, Lifshitz T, Tessler Z: High postdialysis urea rebound can predict intradialytic increase in intraocular pressure in dialysis patients with lowered intradialytic hemoconcentration. Nephron 90: 181-187, 2002
94. Chen SS, Unruh M, Williams M: In quality we trust; but quality of life or quality of care? Semin Dial 29: 103-110, 2016
95. Meijers B, Vanholder R:HEMOrevisited:Why Kt/Vurea only tells part of the story. J Am Soc Nephrol 27: 3235-3237, 2016